Sector portfolio · VC firm · United States

Osage University Partners' Biotech portfolio

Osage University Partners has backed 29 Biotech startups in rounds we track, $2.8B between them, shown by the stage each has reached. The best-funded is Arsenalbio.

29startups backed
4stages
$2.8Braised between them
Series C and laterbiggest stage

Osage University Partners's whole portfolioOsage University Partners's profile

Segment by segment

Series C and later

13 startups · $1.6B raised

  1. ArsenalBioArsenalBio is a programmable cell therapy company that offers advanced CAR T-cell therapies for solid tumors.United States$410M
  2. Spero TherapeuticsSpero Therapeutics develops therapeutics for treatment of gram-negative infections.United States$199M
  3. Atsena TherapeuticsAtsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, focused on developing treatments forUnited States$150M
  4. Kolltan PharmaceuticalsKolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.United States$146M
  5. PMV PharmaceuticalsPMV Pharma is developing first-in-class p53 regulators for the treatment of cancer.United States$144M
  6. Sera PrognosticsSera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.United States$107M
  7. Effector TherapeuticsEffector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.United States$99M
  8. SynthorxSynthorx is a biotechnology company using synthetic biology to synthesize solutions.United States$79M

Stage not reported

8 startups · $574M raised

  1. Vanqua BioVanqua Bio is a biopharmaceutical company based in Chicago, founded in 2019.United States$130M
  2. PPrecisionUnited States$111M
  3. IDImmune DesignImmune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.United States$99M
  4. Ribon TherapeuticsRibon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.United States$90M
  5. SPSasuma PharmaceuticalsUnited States$62M
  6. Virdante PharmaceuticalsVirdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases.United States$60M
  7. Artizan BiosciencesArtizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.United States$14M
  8. LunaPBCLunaPBC is a healthcare company that transforms health data into health breakthroughs.United States$8.4M

Series B

5 startups · $433M raised

  1. Arrakis TherapeuticsArrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.United States$113M
  2. Nocion TherapeuticsNocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.United States$112M
  3. AptinyxAptinyx Inc.United States$76M
  4. LBLandos BiopharmaLandos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.United States$70M
  5. PPionyrUnited States$62M

Series A

3 startups · $177M raised

  1. Vor BiopharmaVor Biopharma is an immuno-oncology company that develops therapies for treating cancer.United States$117M
  2. EscientEscient specializes in providing business strategies, management consulting, and advisory services for various organizations.United States$40M
  3. MMedisixSingapore$20M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Osage University Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Osage University Partners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.